Patient Support Programs

Building on its established reputation as a leading provider of market data, research, and consulting services to the pharmaceutical industry in the MENA region, AMS is proud to announce the expansion of its services to include patient support and affordability programs in Jordan and Iraq. This strategic move underscores AMS’s unwavering commitment to supporting the entire pharmaceutical ecosystem, not just pharmaceutical companies but also the patients who rely on their life-saving medications.

Understanding the Challenges

Accessibility and affordability of medication remain major challenges in Jordan and Iraq. Complexities in healthcare systems, coupled with economic constraints, often prevent patients from accessing the critical treatments they need. This not only has a detrimental impact on patient health outcomes but also poses significant hurdles for pharmaceutical companies seeking to reach their target patients.

AMS to Bridge the Gap

Through its newly established patient support and affordability programs, AMS aims to bridge this gap and address these critical challenges. By leveraging its extensive experience and expertise in the MENA region, AMS will develop and implement customized solutions that will improve patients’ access to essential medications.

- Co-pay assistance programs, patient education initiatives, and collaboration with healthcare providers to streamline access pathways.

- Improve affordability.

- Enhance patient engagement and adherence: By providing educational resources and building trust with patients, AMS will encourage medication adherence and improve treatment outcomes.

Collaboration for a Greater Impact

AMS recognizes that collaboration is key to achieving its goals. The company will work closely with pharmaceutical companies, healthcare providers, patient advocacy groups, and government agencies to develop and implement effective and sustainable patient support and affordability programs.

This expansion marks a significant milestone in AMS’s journey to becoming a one-stop shop for pharmaceutical companies operating in the MENA region. By addressing both market intelligence and patient-centric needs, AMS is committed to driving positive change and improving the health and well-being of patients across the region.